These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17330677)

  • 1. The impact of diabetes mellitus on endothelial dysfunction.
    Varughese GI
    South Med J; 2007 Feb; 100(2):128-9. PubMed ID: 17330677
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.
    van Sloten TT; Henry RM; Dekker JM; Nijpels G; Unger T; Schram MT; Stehouwer CD
    Hypertension; 2014 Dec; 64(6):1299-305. PubMed ID: 25225211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes.
    Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K
    Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction and cardiovascular disease--the lull before the storm.
    Marx N; Grant PJ
    Diab Vasc Dis Res; 2007 Jun; 4(2):82-3. PubMed ID: 17654440
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular and Endothelial Function in Youth with Type 2 Diabetes Mellitus.
    Shah AS; Urbina EM
    Curr Diab Rep; 2017 Jun; 17(6):36. PubMed ID: 28432570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of measures of endothelial function to stratify risk.
    Charbonneau F
    Can J Cardiol; 2001 May; 17 Suppl A():18A-21A. PubMed ID: 11381290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma omentin levels are associated with vascular endothelial function in patients with type 2 diabetes at elevated cardiovascular risk.
    Hayashi M; Morioka T; Hatamori M; Kakutani Y; Yamazaki Y; Kurajoh M; Motoyama K; Mori K; Fukumoto S; Shioi A; Shoji T; Emoto M; Inaba M
    Diabetes Res Clin Pract; 2019 Feb; 148():160-168. PubMed ID: 30641171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
    Hadi HA; Carr CS; Al Suwaidi J
    Vasc Health Risk Manag; 2005; 1(3):183-98. PubMed ID: 17319104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of postprandial hyperglycemia in the development of cardiovascular diseases in type 2 diabetes mellitus].
    Shvarts V
    Klin Med (Mosk); 2009; 87(11):17-24. PubMed ID: 20143560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction potentially interacts with impaired glucose metabolism to increase cardiovascular risk.
    Jia G; Sowers JR
    Hypertension; 2014 Dec; 64(6):1192-3. PubMed ID: 25225204
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased arterial stiffness is associated with reduced plasma levels of beta-carotene in treated hypertensive patients with type 2 diabetes mellitus.
    Chung HK; Kang B; Lee JH; Shim JY; Park S; Lee SH; Park YK; Park E; Chung N; Shin MJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):e9-e11. PubMed ID: 19505810
    [No Abstract]   [Full Text] [Related]  

  • 13. [Endothelial function in high risk cardiovascular patients].
    Káli A; Jánosi A
    Orv Hetil; 2006 Jan; 147(3):99-106. PubMed ID: 16515028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the MONICA/KORA Augsburg Study.
    Thorand B; Baumert J; Döring A; Schneider A; Chambless L; Löwel H; Kolb H; Koenig W
    Thromb Haemost; 2006 Jan; 95(1):134-41. PubMed ID: 16543972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["New" serum marker for cardiovascular risk].
    Mertz DP
    Dtsch Med Wochenschr; 2004 May; 129(21):1216; author reply 1216. PubMed ID: 15160328
    [No Abstract]   [Full Text] [Related]  

  • 16. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.
    van Etten RW; de Koning EJ; Verhaar MC; Gaillard CA; Rabelink TJ
    Diabetologia; 2002 Jul; 45(7):1004-10. PubMed ID: 12136399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endothelial dysfunction in patients with systemic lupus erythematosus].
    Serikova SIu; Kozlovskaia NL; Shilov EM
    Ter Arkh; 2010; 82(2):70-4. PubMed ID: 20387683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice.
    Liang W; Tan CY; Ang L; Sallam N; Granville DJ; Wright JM; Laher I
    J Physiol Sci; 2008 Dec; 58(6):405-11. PubMed ID: 18845058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impairment effect of diabetes mellitus combined with hypertension on artery vasodilation].
    Ma LL; Zhao SP; Li J
    Hunan Yi Ke Da Xue Xue Bao; 2000 Dec; 25(6):553-6. PubMed ID: 12516402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophilin-A: a potential screening marker for vascular disease in type-2 diabetes.
    Ramachandran S; Kartha CC
    Can J Physiol Pharmacol; 2012 Aug; 90(8):1005-15. PubMed ID: 22647032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.